A proof of concept study on the effect of tianeptine on opioidinduced respiratory depression

Trial Profile

A proof of concept study on the effect of tianeptine on opioidinduced respiratory depression

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2015

At a glance

  • Drugs Tianeptine (Primary)
  • Indications Respiratory insufficiency
  • Focus Proof of concept; Therapeutic Use
  • Acronyms STORD
  • Most Recent Events

    • 10 Jan 2015 Planned number of patients changed from 16 to 32 as reported by Netherlands Trial Register.
    • 18 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top